Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Evome Medical Technologies Inc LNDZF


Primary Symbol: V.EVMT

Healthcare Medical Devices
Evome Medical Technologies Inc. is an international medical device company, which is focused on human performance and rehabilitative solutions. The Company’s products include Biodex Rehab product, Damar Plastics product, Mio-Guard product, Simbex services, and SDP product. Its Biodex Rehab products include Isokinetic Systems, Gait Trainer, Body-Weight Supported Training, Cycles and Ergometers... see more

Recent & Breaking News (TSXV:EVMT)

Evome Medical Technologies Posts Third Quarter 2024 Results, Generates $424,000 in Adjusted EBITDA on Stable Revenues, Further Reduces Debt

GlobeNewswire 11 hours ago

Evome Medical Technologies Announces Results From Its Annual General and Special Meeting of Shareholders

GlobeNewswire November 8, 2024

Evome Medical Technologies Reviews Highlights of Low-CapEx Revenue Growth Plan

GlobeNewswire August 15, 2024

Evome Medical Technologies Reports Second Quarter 2024 Financial Results

GlobeNewswire August 12, 2024

Evome Medical Technologies Retains irlabs for Investor Relations Services

GlobeNewswire July 3, 2024

Evome Medical Technologies Announces Securities Issuances

GlobeNewswire June 14, 2024

Evome Medical Technologies Announces Update Call with CEO Mike Seckler for Tuesday, June 4, 2024; Provides Update on Strong Q2

GlobeNewswire June 3, 2024

Evome Medical Technologies Announces Biodex Generated 100% Sales Growth Comparing April 2024 to January 2024, Plans to Shed Remaining Non-Core Units to Pay Off Remaining Acquisition Debt

GlobeNewswire May 30, 2024

Evome Strengthens Major Creditor Relationship After the Sale of the Simbex Unit to Riddell, LOI Related to Simbex Acquisition Debt is Cancelled

GlobeNewswire April 12, 2024

Canadian Investment Regulatory Organization Trade Resumption - EVMT

Canada NewsWire April 2, 2024

Canadian Investment Regulatory Organization Trading Halt - EVMT

Canada NewsWire April 2, 2024

Evome Sells Simbex R&D Business Unit to Riddell for $4.83M in Cash; Improves Balance Sheet, Reduces Biodex Acquisition Debt

GlobeNewswire April 2, 2024

Evome Medical Technologies Punctuates Turn Around Plan with Strong Fourth Quarter Resulting in Positive Annual Adjusted EBITDA for Fiscal Year 2023

GlobeNewswire April 1, 2024

Evome Medical Engages ICP Securities Inc. for Automated Market Making Services

GlobeNewswire February 27, 2024

Evome Medical Technologies Bolsters Board of Directors with Appointment of Strategic Senior Healthcare Executives Wayne Anderson and Bill Garbarini, Appoints Kenneth Kashkin, MD, as Chairman

GlobeNewswire February 15, 2024

Evome Medical Technologies Executes Non-Binding Letter of Intent to Extend Remaining Simbex Acquisition Debt to June 2025; Increases Sales Targets by 7.5% for Biodex Distribution Contracts; Raises Biodex Product Pricing by 2% for 2024

GlobeNewswire February 8, 2024

Evome Medical Technologies Reduces Acquisition Debt, Bolsters Management Team to Support SpaceTeck Knee(TM) and Reactive Step Trainer 2024 Product Roll-Out

GlobeNewswire January 31, 2024

Salona Global Finalizes Name Change to Evome Medical Technologies to Reflect Turn Around and New Innovation Focus; Restructures Board of Directors

GlobeNewswire January 18, 2024

Salona Global Announces Exclusive Partnership with Recently Launched U.S. Military Veteran (VA) Focused Distribution Company

GlobeNewswire January 11, 2024

Salona Global Announces the Debut of the Biodex Reactive Step Trainer, a Revolutionary Balance Training System to Reduce Falls; Commences AI Enabled Software Component

GlobeNewswire December 18, 2023